losartan and epidermal growth factor

losartan has been researched along with epidermal growth factor in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chevalier, RL; Chung, KH; Gomez, RA1
Hollenberg, MD; Laniyonu, A; Saifeddine, M; Yang, SG1
Gomez, RA; Hilgers, KF; Pentz, ES1
Burns, KD; Zimpelmann, J1
Ahn, HJ; Bang, BK; Kim, J; Kim, SK; Kim, WY; Kim, YO; Kim, YS; Park, JH; Shin, MJ; Yang, CW1
Kolachana, P; Lawsin, LM; Moore, J; Perlman, A; Ringel, MD; Saji, M1
Flannery, PJ; Spurney, RF1

Other Studies

7 other study(ies) available for losartan and epidermal growth factor

ArticleYear
Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction.
    The American journal of physiology, 1995, Volume: 268, Issue:6 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Blotting, Northern; Clusterin; DNA; Epidermal Growth Factor; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycoproteins; Imidazoles; Kidney; Losartan; Molecular Chaperones; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Ureteral Obstruction

1995
Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:2

    Topics: Angiotensin II; Animals; Biphenyl Compounds; Calcium; Catechols; Cyclohexanones; Dose-Response Relationship, Drug; Epidermal Growth Factor; Genistein; Guinea Pigs; Imidazoles; In Vitro Techniques; Indoles; Indomethacin; Isoflavones; Losartan; Male; Muscle, Smooth; Nitriles; Protein-Tyrosine Kinases; Pyridines; Quinacrine; Signal Transduction; Stomach; Tetrazoles; Tyrphostins

1993
Angiotensin-dependent gene expression in the developing rat kidney.
    Kidney international. Supplement, 1998, Volume: 67

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Antihypertensive Agents; Blotting, Northern; Endothelial Growth Factors; Epidermal Growth Factor; Gene Expression Regulation, Developmental; Growth Substances; Kidney; Losartan; Lymphokines; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1998
Angiotensin II AT(2) receptors inhibit growth responses in proximal tubule cells.
    American journal of physiology. Renal physiology, 2001, Volume: 281, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Calcium; Cell Division; Cell Line; DNA; Epidermal Growth Factor; Imidazoles; Immunoblotting; Kidney Tubules, Proximal; Losartan; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatases; Pyridines; Radioligand Assay; Receptors, Angiotensin; Transfection; Vanadates

2001
Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney.
    Kidney international, 2001, Volume: 60, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cyclosporine; Diet, Sodium-Restricted; Epidermal Growth Factor; Fibrosis; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Glomerulus; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System

2001
Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.
    Annals of clinical and laboratory science, 2004,Summer, Volume: 34, Issue:3

    Topics: Angiotensin II; Animals; Butadienes; Cell Line; Chromones; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Epidermal Growth Factor; Glomerular Mesangium; Immunoblotting; Losartan; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tyrphostins

2004
Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
    Nephron. Experimental nephrology, 2006, Volume: 103, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Line; Coculture Techniques; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Green Fluorescent Proteins; Heparin-binding EGF-like Growth Factor; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Kidney Glomerulus; Losartan; Metalloproteases; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Phosphorylation; Podocytes; Protease Inhibitors; Pyridines; Recombinant Fusion Proteins; Time Factors; Transcriptional Activation

2006